Edoxaban-Mepha 15 mg

Edoxaban-Mepha 15 mg is a medicine authorised by Swissmedic under authorisation number 70394. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 February 2026 and the authorisation is limited until 02 February 2031. ATC code B01AF03 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 70394
  • ATC B01AF03
  • Synthetic medicines
Authorisation data
Authorisation number70394
NameEdoxaban-Mepha 15 mg
Full nameEdoxaban-Mepha 15 mg, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB01AF03
First authorisation03 February 2026
Authorisation validity02 February 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Edoxaban-Mepha 15 mg, FilmtablettenB03 February 2026
2Edoxaban-Mepha 30 mg, FilmtablettenB03 February 2026
3Edoxaban-Mepha 60 mg, FilmtablettenB03 February 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)B01AF0306.03.0.B
230Tablette(n)B01AF0306.03.0.B
3100Tablette(n)B01AF0306.03.0.B
4100Tablette(n)B01AF0306.03.0.B
530Tablette(n)B01AF0306.03.0.B
6100Tablette(n)B01AF0306.03.0.B
7100Tablette(n)B01AF0306.03.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Edoxaban-Mepha 15 mg authorised in Switzerland?

Yes. Edoxaban-Mepha 15 mg is authorised by Swissmedic under authorisation number 70394, data as of 01 September 2026. The authorisation is limited until 02 February 2031.

Which dispensing category does Edoxaban-Mepha 15 mg have?

Edoxaban-Mepha 15 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Edoxaban-Mepha 15 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com